Service Hotline +86 400-068-7188
Service Hotline +86 400-068-7188
China Pharmaceutical Service Industry Report (2013-2017), Development Patterns and Investment Prospects
A must-have for enterprise medium to long-term strategic planning
Without deep industry knowledge, it will be difficult to gain any return
English Version：USD7900
Including: Paper back + Electronic Copy + Invoice
Customer Hotline：+86 755 - 82925195 / 82925295
Free Hotline：+86 400-068-7188After-sales Hotline： +86 755-33013088
The Ministry of Commerce of the People's Republic of China designated Qianzhan Industrial Research Institute as the only "regional workstation for dealing with trade friction" in the Guangdong-Hong Kong-Macao Greater Bay Area
Customer Hotline：+86 755 - 82925195 / 82925295
Free Hotline：+86 400-068-7188
0755 - 82925195
400-068-7188
We are aware of that the content of our products have been stolen by some ones who changed the design and used it to deceive customers as it is their own products. Customers who are misled may experience no product received or an incomplete product.
Therefore, Qianzhan Industrial Research Institute encourage you to arrange an in-person visit to our company before you make the purchase.
Qianzhan has the sole copyright of all research reports. We have never had partnership or affiliated with any third party agent. Please recognize the"
"trademark when purchasing reports.To have better investment return or strategic outcomes, you must have a forward-looking vision. Qianzhan Industrial Research Institute - China's leading industry consulting institutions provide you with all the things you need in business!
* The table of contents and the rest of this report are originally created by Qianzhan. Without any prior written permission, it is prohibited to copy or reproduce in any way. To have better investment return or strategic outcomes, you must have a forward-looking vision!
Table of Contents
Content Summary
Chapter 1: Review of China pharmaceutical service industry development
1.1 research units and research methods of the report
1.1.1 introduction of research units of the report
1.1.2 overview of research methods of the report
(1) literature review
(2) qualitative analysis
(3) case study
1.2 Summary of related concepts of pharmaceutical service
1.2.1 related definitions of pharmaceutical service
(1) pharmaceutical service
(2) clinical pharmacy
(3) rational drug use
1.2.2 basic elements of pharmaceutical service
1.2.3 main contents of pharmaceutical service
(1) modern pharmaceutical VS traditional pharmaceutical
(2) main contents of pharmaceutical service
1.3 research of compensation mechanism of pharmaceutical service
1.3.1 definition of pharmaceutical service fee
(1) related concepts
(2) definition of pharmaceutical service fee
(3) category of pharmaceutical service fee
(4) positioning of pharmaceutical service fee
(5) role of of pharmaceutical service fee
1.3.2 connotation of pharmaceutical service fee
(1) connotation of pharmaceutical service fee in the USA
(2) connotation of pharmaceutical service fee in Japan
(3) exploration of connotation of pharmaceutical service fee in China
1.3.3 research of pharmaceutical service compensation mode
(1) compensation mode through difference of purchase price and sales price of the drugs
1) addition of fixed difference rate
2) t addition of different difference rate
3) the form of volume discounts
(2) compensation mode through the establishment of separate charge
1) drug adjustment fee
2) other pharmaceutical service charges
(3) mixed compensation mode
1) meaning
2) typical examples
(4) foreign pharmaceutical service compensation mode reference to China
1.3.4 charging methods of drug adjustment fee
(1) by prescription
(2) by person
(3) by the number of days in hospital
(4) by prescription entry
(5) by packing of medical service
(6) by types of prescription drugs
(7) by the amount of prescription drugs
Chapter 2: Analysis of market environment of Chinese pharmaceutical service industry
2.1 analysis of policy environment of pharmaceutical service industry
2.1.1 requirements of the new health care reform for pharmaceutical service
(1) standardized clinical use of drugs
(2) regulate patients of rational drug use
(3) drug quality management
2.1.2 the new health care reform's impact on pharmaceutical service
(1) separation of medicine and doctors and practicing multi-pilot
(2) implementation of the national essential drugs
(3) licensed pharmacists will get more attention
2.1.3 related policies and regulations of pharmaceutical service industry
2.2 analysis of social environment of pharmaceutical service industry
2.2.1 monitoring of adverse drug reactions
(1) the concept of adverse drug reactions
(2) monitoring of adverse drug reactions
1) quantity of national adverse drug reactions
2) distribution of national adverse drug reactions
2.2.2 characteristics of adverse drug reactions
(1) classification of adverse drug reaction species
1) the chemicals category involved in the total number of cases reported
2) specific varieties ranking of anti-infectives
(2) distribution of routes of adverse drug reactions
(3) TCM injection risks
(4) safety conditions of the national essential drugs
2.3 analysis of supply and demand environmental of pharmaceutical service industry
2.3.1 analysis of the supply side of pharmaceutical service
(1) total number of clinical pharmacists in medical institutions
(2) distribution of types of clinical pharmacists in medical institutions
(3) distribution of qualifications of clinical pharmacists in medical institutions
(4) distribution of academic qualifications of clinical pharmacists in medical institutions
2.3.2 analysis of the demand side of pharmaceutical service
(1) analysis of the demands from doctors, nurses and patients for pharmaceutical service
1) the demands from doctors
2) the demands from nurses
3) the demands from patients
(2) implications of the demands from doctors, nurses and patients for pharmaceutical service
1) knowledge structure of pharmaceutical major
2) training methods of clinical pharmacist
3) belongings of the Department of Clinical pharmacy
2.4 analysis of technology environment of pharmaceutical service industry
2.4.1 related research statistics of pharmaceutical service
(1) statistics of number changes in literature
(2) distribution of authors in institutions
(3) classification of research areas
2.4.2 related research results of pharmaceutical service
(1) cognitive of medical staff and patients in pharmaceutical service
(2) the coverage of diseases and the types of drugs in pharmaceutical service literature
(3) impact of pharmaceutical service intervention on disease treatment
Chapter 3: Analysis of status quo and prospects of Chinese pharmaceutical service industry
3.1 overview of pharmaceutical service development
3.1.1 pharmaceutical service system
3.1.2 main bodies of pharmaceutical service
(1) pharmaceutical service organization
(2) main bodies of pharmaceutical service
(3) pharmaceutical service hardware
3.1.3 pharmaceutical service regulations
3.2 development strategies and recommendations of pharmaceutical service
3.2.1 factors of pharmaceutical service development
(1) government
(2) hospital
(3) higher education
(4) pharmacist
1) the traditional concept restraints the behavior of pharmacist
2) the education of pharmacists and their own knowledge structure
3) lack of knowledge of the humanities is the difficulty of clinical pharmacy
3.2.2 development strategies of pharmaceutical service
(1) governments should strengthen policy support for pharmaceutical service
(2) hospitals should increase attention on pharmaceutical service
(3) education departments should plan well clinical pharmacy training mode
(4) pharmacists themselves should strive, explore the development road for practitioners
3.3 discussion of development of pharmaceutical service for the elderly
3.3.1 features of medication for the elderly
(1) elderly physiological characteristics
(2) elderly psychological characteristics
(3) pharmacokinetic characteristics
3.3.2 problems for safe elderly medication
(1) no abide by the doctor
(2) improper drug selection
(3) not grasp the methods of drug use
(4) repeat medication and drug name confusion
(5) unreasonable combination of drugs
(6) supplementary of calcium and nutritional medicine
3.3.3 principles for safe elderly medication
(1) not use or little use drugs
(2) rational drug selection
(3) appropriate dose selection
(4) moderate drug treatment
(5) improving medication adherence of the elderly
(6) note the influence of drugs on other diseases of the elderly
3.3.4 guidelines for safe elderly medication
(1) medication supervision
(2) condensed treatment plan
(3) drug counseling service
(4) determine plan of the priority treatment
(5) conduct pharmaceutical lectures
(6) establish medical history and pharmacist service cards
3.4 discussion on the development of pediatric pharmaceutical service
3.4.1 Children's physiological characteristics
3.4.2 features of pediatric pharmaceutical service
(1) poor compliance
(2) children with special physiological and psychological characteristics
(3) close attention to the treatment of children with specific physical quality
(4) difficult and inaccurate expression of adverse drug reactions
3.4.3 discussion on pediatric pharmaceutical service
(1) application of anti-infective drugs
(2) application of antipyretic analgesics
(3) application of steroids
(4) application of the vascular and nervous drugs
(5) application of proprietary Chinese medicines
(6) application of other drugs
Chapter 4: Analysis of development models and case study of Chinese pharmaceutical service industry
4.1 path selection of clinical pharmaceutical service models
4.1.1 3 levels of Chinese clinical pharmaceutical service model
4.1.2 path selection of clinical pharmaceutical service models
(1) clinical pharmaceutical education reform
(2) clinical pharmaceutical service requires system platform
(3) to improve continuing education of the hospital pharmacy
(4) step up publicity to promote the development of clinical pharmaceutical service
4.2 Analysis of common models of pharmaceutical service and reflection
4.2.1 classification of common models of pharmaceutical service
4.2.2 analysis of common models of pharmaceutical service
(1) model of clinical pharmaceutical service
(2) model of counter ( window ) service
(3) model of drug counseling room
(4) model of hotline service
(5) model of pharmaceutical service website
(6) model of drug lectures
4.2.3 reflections on pharmaceutical service model
(1) reflections on pharmaceutical service model
1) supervision and testing should be an important part
2) to strengthen the pharmaceutical training for nurses and mentoring
3) cannot separate drug counseling room from the drug supply chain
4) window service model should pay attention to improve patients’ medication compliance
(2) essential connotation of pharmaceutical service
4.3 development status quo and prospects of the model of whole-process pharmaceutical service
4.3.1 features of the whole-process pharmaceutical service
4.3.2 implementation status quo of the whole-process pharmaceutical service
(1) implementation contents of the whole-process pharmaceutical service
(2) implementation status quo of the whole-process pharmaceutical service in hospitals
(3) feasible countermeasures for implementation of the whole-process pharmaceutical service in hospitals
4.4 development status quo and prospects of the model of life-cycle pharmaceutical service
4.4.1 definition of life-cycle pharmaceutical service
4.4.2 characteristics of life-cycle pharmaceutical service
4.4.3 platform construction of life-cycle pharmaceutical service
4.4.4 prospects of life-cycle pharmaceutical service
4.5 development status quo and prospects of the model of detailed pharmaceutical service
4.5.1 overview of detailed pharmaceutical service
(1) definition of detailed pharmaceutical service
(2) reflection of detailed pharmaceutical service
4.5.2 model of detailed pharmaceutical service
(1) specialization of drug layout
(2) systematic medication instructions
(3) specialization of drug counseling
(4) collectivization of QC management
(5) humanization of point and sphere integration
4.5.3 prospects of the development of detailed pharmaceutical service
4.6 discussion on cases of the development of pharmaceutical service models
4.6.1 Tianjin People 's Hospital
(1) introduction of the hospital’s " one-stop" service model
1) background of "one-stop " service model
2) hospital outpatient "one-stop " service
(2) to change the traditional model of outpatient pharmaceutical service
1) humane counter service model
2) the implementation of flexible work shifts
3) the establishment of outpatient drug counseling service
(3) redesign measures of outpatient pharmaceutical business process
1) the application of computer network software
2) the introduction of pneumatic logistics system
(4) problems of outpatient "one-stop " service model and countermeasures
4.6.2 Pharmaceutical Department of Xuanwu Hospital of Capital Medical University
(1) clinical pharmacists and pharmaceutical pharmacists share clinical cases
(2) clinical pharmacists involve in the work of daily oral drug arrangement
(3) clinical pharmacists led pharmaceutical pharmacists to do antimicrobial use and management
(4) clinical pharmacists and ward pharmacists cooperate to form the whole-process pharmaceutical service
4.6.3 Shenzhen Longgang Community
(1) before admission
1) distribute pharmaceutical promotional materials
2) establish community residents' health records
3) establish health education and pharmaceutical service promotion column
4) establish community service website or pharmacist blog
(2) admission ongoing
1) monitoring of medication process
2) improve the relevant information , audit prescription
3) together with physicians in clinical admission , grasp first-hand information
(3) after treatment
1) home visit follow-up
2) telephone follow-up
3) communication network
4) health records and data collation
(4) feasibility of community pharmaceutical service model
(5) prospects of community pharmaceutical service model
Chapter 5: Status quo of Chinese hospital pharmaceutical service and prospects
5.1 research on theoretical model of hospital pharmaceutical service
5.1.1 introduction of theoretical model of hospital pharmaceutical service
5.1.2 research on theoretical model of hospital pharmaceutical service
(1) correct leadership - "fish eyes"
(2) common vision - " fish head"
(3) pharmaceutical service mechanism - " fish body"
(4) promotion and safeguard mechanism of pharmaceutical service - " fish scale "
(5) following actions - " fishtail "
(6) macro environment - "water"
Currently, the pharmaceutical service model has no uniform classification, nomenclature. Based on different places and methods of pharmaceutical service, this report summarizes the pharmaceutical service as follows: model of clinical pharmacist service, model of drug counseling room, model of the window (counter) service, model of hotline service, model of drug lectures and pharmaceutical service website.
With the deepening of China's medical reform, the general increase of people's health awareness and legal awareness, more and more consumers begin to demand the rights to know the medicine and medicine selection and f also put forward higher requirements for pharmaceutical service. Pharmaceutical service is no longer simple medicine deployment and distribution, but to provide direct, responsible pharmaceutical service technology for patients. Along with medical treatment and medical care, it accomplishes the goal of providing patients with life quality.
Currently, the pharmaceutical service model has no uniform classification, nomenclature. Based on different places and methods of pharmaceutical service, this report summarizes the pharmaceutical service as follows: model of clinical pharmacist service, model of drug counseling room, model of the window (counter) service, model of hotline service, model of drug lectures and pharmaceutical service website. In addition, new pharmaceutical service models such as model of the whole process of pharmaceutical service, model of fine pharmaceutical service are also deepening and develop. Pharmaceutical service is an important part of the hospital. Excellent service directly reduces the adverse consequences caused by the irrational drug use, reduces unnecessary losses and waste of resources, bring good economic and social benefits for the hospital.
This report mainly analyzes Chinese pharmaceutical service industry’s development environment, market environment, development status and countermeasures, development models and cases, status quo and prospects of pharmaceutical service, status quo and cases of pharmaceutical services of social pharmacies and drug retailers, domestic and international community pharmaceutical service model and construction programs, case study of the industry-leading medical institutions. Meanwhile, based on first-hand market data of the whole industry in the past five years, it can allow you to fully and accurately grasp market trends and trends throughout thepharmaceutical service industry.
The greatest feature of this report is forward-looking and timeliness. Based on the development path and years of practical experience, it makes careful analysis and prediction of the future development trends of pharmaceutical service industry. It is a rare quality for pharmaceutical service enterprises, investment companies to accurately understand the latest developments in thepharmaceutical service industry grasp market opportunities, make the right business decisions and clear corporate directions. It is also a heavyweight report on the comprehensive system analysis of pharmaceutical service industry.
This report will help pharmaceutical service enterprises, investment companies accurately understand the latest developments of the industry and early detect blank points of industry market, opportunities, growth and profitability points ...... it will help prospectively grasp unmet market needs and trends of the industry and become a good advantage for sustainable development, effectively avoid the investment risks from the industry, more efficiently consolidate or expand appropriate strategic target markets, and firmly grasp the initiative authority in market competition.
During the writing process, the report is supported strongly by China Surface Engineering Association, the Ministry of Industry,the National Economic Information Center, the National Bureau of Statistics the National Bureau of Customs, the International Institute of Information, Ministry of Commerce of China, Tsinghua University Library, Market and Economy Research Institute of the State Council’s Development Research Center and other institutions. We express our special thanks!
Pls note: This report includes a lot of market data, especially enterprise ranking data, it is for business reference purposes only, we hope corporate advertising clients do not use for advertisement ranking comparison. Otherwise, all the consequences caused, Forward Business will not bear!
Special Notes: Neglection of some subtle signs of dramatic changes in the external environment and untimely update the strategic decisions with environmental changes can lead to loss of competitive advantages. Truly successful enterprises (organizations), consciously or unconsciously, will do scientific analysis of the external environment and thus formulate crucial and scientific business strategies!
Qianzhan sincerely wishes every ambitious enterprise can develop a high-quality business decisions and continue to achieve success!
Qianzhan Industry Research Institute
Pharmaceutical Service IndustryResearch Group
The National Bureau of Statistics Foreign-related investigation Permission
National Innovation Company and Dual Software Certified Enterprise
The only DRC desginated Enterprise of the Industry Yearbook
National Ministry of Commerce designated Industrial Early Warning and Monitoring Workstation
Guangdong Province Enterprise of Observing Contract and Valuing Credit
Qianzhan is an industry consulting service provider with national innovation company qualification, independent research and development of industrial big data and Dual Software Certification.
Qianzhan is a consulting and research organization that has been engaged in business consulting for over 16 years in China.
Qianzhan is a consulting service provider with a team of nearly 300 industrial researchers and analysts.
Qianzhan is a consulting service provider with an in-house expert pool of 1200 experts.
Qianzhan is a research and consulting organization that have served 180000 clients and received over positive comments from 100000 of our clients.
Qianzhan is an industry research and consulting organization that has been designated by the highest authority, the DRC, to prepare the yearbook.
Qianzhan is an industry planning and consulting organization that adopts the internationally synchronized SCP scientific analysis model and the perfect industry chain research map to guide the business planning and consulting.
Qizhan is a consulting service organization that helps enterprises to solve the five aspects of industry research, planning, strategic design, capital operation and implementation.
Free Hotline：+86 400-068-7188
Customer Hotline：+86 755 - 82925195 / 82925295
Email Address：service@qianzhan.com
3rd Floor, FIYTA Building West, High Tech South Avenue 1, Nanshan District, Shenzhen, China
Location：Rm.1106, Building 1, Jiayu International Plaza, Songhu Road, Yangpu District,
Shanghai, China
Quality Assured
Offer a forward-looking vision to all of our customers.
Customer Service
We welcome any feedbacks and suggestions to make our customers 100% satisfied.
Qualification Certificates
Having more than 20 qualification certificates, including Innovation Company Certificate and Foreign-related investigation Permission etc.
Customers Testimonials
Thank you for recognizing our high quality products and professional, rigorous and sincere service.
